Pharma-Bio Serv Inc
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and pr… Read more
Pharma-Bio Serv Inc (PBSV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: 0.023x
Based on the latest financial reports, Pharma-Bio Serv Inc (PBSV) has a cash flow conversion efficiency ratio of 0.023x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($279.67K) by net assets ($11.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharma-Bio Serv Inc - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Pharma-Bio Serv Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharma-Bio Serv Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharma-Bio Serv Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NEP Realty and Industry Public Company Limited
BK:NEP
|
-0.011x |
|
IVF_INSPIRE IVF
BK:IVF
|
N/A |
|
New England Realty Associates LP
NYSE MKT:NEN
|
-0.034x |
|
Ilyda SA
AT:ILYDA
|
0.032x |
|
Kohinoor Foods Limited
NSE:KOHINOOR
|
-0.740x |
|
Standard Industries Limited
NSE:SIL
|
0.540x |
|
Healthy Choice Wellness Corp.
NYSE MKT:HCWC
|
-0.052x |
|
Home Pottery Public Company Limited
BK:HPT
|
0.010x |
Annual Cash Flow Conversion Efficiency for Pharma-Bio Serv Inc (2007–2025)
The table below shows the annual cash flow conversion efficiency of Pharma-Bio Serv Inc from 2007 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $11.91 Million | $-214.89K | -0.018x | +56.35% |
| 2024-10-31 | $13.72 Million | $-566.70K | -0.041x | -135.24% |
| 2023-10-31 | $16.13 Million | $1.89 Million | 0.117x | +227.70% |
| 2022-10-31 | $16.56 Million | $592.46K | 0.036x | -15.91% |
| 2021-10-31 | $18.91 Million | $804.84K | 0.043x | -36.63% |
| 2020-10-31 | $22.72 Million | $1.53 Million | 0.067x | +162.68% |
| 2019-10-31 | $20.61 Million | $-2.21 Million | -0.107x | -158.38% |
| 2018-10-31 | $20.26 Million | $3.72 Million | 0.184x | +322.87% |
| 2017-10-31 | $20.75 Million | $-1.71 Million | -0.082x | -353.07% |
| 2016-10-31 | $21.81 Million | $709.65K | 0.033x | +91.79% |
| 2015-10-31 | $21.96 Million | $372.61K | 0.017x | -89.55% |
| 2014-10-31 | $20.51 Million | $3.33 Million | 0.162x | -47.91% |
| 2013-10-31 | $18.05 Million | $5.63 Million | 0.312x | +63.22% |
| 2012-10-31 | $12.88 Million | $2.46 Million | 0.191x | -26.50% |
| 2011-10-31 | $8.24 Million | $2.14 Million | 0.260x | +182.64% |
| 2010-10-31 | $5.07 Million | $466.00K | 0.092x | -80.27% |
| 2009-10-31 | $4.66 Million | $2.17 Million | 0.466x | +19.51% |
| 2008-10-31 | $4.05 Million | $1.58 Million | 0.390x | -84.99% |
| 2007-10-31 | $2.17 Million | $5.63 Million | 2.598x | -- |